Quick Answer
MYRIAD GENETICS INC reported Revenue From Contract With Customer Excluding Assessed Tax of $824.50 million for the year ending 2025.
- MYRIAD GENETICS INC showed a decrease of -1.6% in Revenue From Contract With Customer Excluding Assessed Tax from 2024 to 2025.
- This data is from MYRIAD GENETICS INC's annual report (Form 10-K), filed with the SEC on February 24, 2026.
- XBRL data for this metric is available from 2015 to 2025 (12 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 12 years of available data (2015 to 2025), MYRIAD GENETICS INC's Revenue From Contract With Customer Excluding Assessed Tax has grown by 14.1%.
- Historical annual values: Fiscal year 2025: $824.50 million | Fiscal year 2024: $837.60 million | Fiscal year 2023: $753.20 million | Fiscal year 2022: $678.40 million | Fiscal year 2021: $690.60 million | Fiscal year 2020: $557.10 million | Fiscal year 2020: $638.60 million | Fiscal year 2019: $851.10 million | Fiscal year 2018: $743.70 million | Fiscal year 2017: $728.70 million | Fiscal year 2016: $740.50 million | Fiscal year 2015: $722.50 million.
- Data sourced from SEC EDGAR public filings as of June 24, 2026.
Last verified: